Indeed, circulating levels of the C5a complement factor are increased in proportion to the seriousness of COVID-19, and high expression levels of C5aR1 receptors are described in myeloid cells, supporting a role for the C5a–C5aR1 axis in the pathophysiology of severe COVID-19 [73]. This evidence concerns the gene C5AR1 and COVID-19.